Other pathways, such as CCKR signaling map and Gonadotropin-releasing hormone receptor pathway have not been previously associated with FSGS and need to be validated regarding their specific relevance in this context. This evidence concerns the gene GNRHR and focal segmental glomerulosclerosis.